Finance

Lists
VERA:NASDAQ
Vera Therapeutics, Inc
29,42 USD
-1,37%
(-0,41) 1D
29,42 USD
0,00% (0,00)
After hours
Closed: 6-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
29,98 USD
High
30,10 USD
Low
28,37 USD
Mkt. cap
2,16 млд
Avg. vol.
2,38 млн
Volume
2,40 млн
52-wk high
56,05 USD
52-wk low
23,05 USD
EPS
-5,86 USD
Beta
1,06
Shares outstanding
72,06 млн
No. of employees
361
Open
29,98 USD
High
30,10 USD
Low
28,37 USD
Mkt. cap
2,16 млд
Avg. vol.
2,38 млн
Volume
2,40 млн
52-wk high
56,05 USD
52-wk low
23,05 USD
EPS
-5,86 USD
Beta
1,06
Shares outstanding
72,06 млн
No. of employees
361
News stories
From web sources and news partners
About Vera Therapeutics, Inc
CEO-
Employees361
Founded2016
HeadquartersБрисбен, Калифорния, Америка Кошмо Штаттары
Sector-
Websiteveratx.com
Analyst ratings
Based on 12 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current 29,42 USD
100,00 USD (+239,90%)
Average
75,40 USD (+156,29%)
Lowest
34,00 USD (+15,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
90,00 USD
+205,9%
10/01/2026
Unknown Analyst
Jefferies
Buy
Maintained
59,00 USD
+100,5%
09/16/2026
Laura Chico
Wedbush
Hold
Maintained
34,00 USD
+15,6%
09/16/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
Dina Ramadane
Bank of America Securities
Buy
Reiterated
66,00 USD
+124,3%
09/15/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
70,00 USD
+137,9%
09/15/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
90,00 USD
+205,9%
09/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
09/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
78,00 USD
+165,1%
08/31/2026
Vamil Divan
Guggenheim
Buy
Reiterated
76,00 USD
+158,3%
08/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
100,00 USD
+239,9%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
91,00 USD
+209,3%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
70,00 USD
+137,9%
06/11/2026
Paul Choi
Goldman Sachs
Buy
Maintained
90,00 USD
+205,9%
06/05/2026
Andy Chen
Wolfe Research
Buy
Maintained
88,00 USD
+199,1%
06/02/2026
Unknown Analyst
Wedbush
Hold
Maintained
35,00 USD
+19%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
56,47 млн
59,31 млн
86,01 млн
60,08 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,46 млн
34,90 млн
39,12 млн
52,41 млн
Operating expense
83,93 млн
94,21 млн
125,13 млн
112,49 млн
Total operating expenses
83,93 млн
94,21 млн
125,13 млн
112,49 млн
Operating income
-83,93 млн
-94,21 млн
-125,13 млн
-112,49 млн
Other non operating income
-137,00 миң
-303,00 миң
-32,00 миң
-483,00 миң
EBT including unusual items
-80,29 млн
-91,10 млн
-121,03 млн
-109,47 млн
EBT excluding unusual items
-80,29 млн
-90,90 млн
-120,63 млн
-109,47 млн
Income tax expense
-
1,00 миң
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-80,29 млн
-91,10 млн
-121,03 млн
-109,47 млн
Net profit margin
-
-
-
-
Earnings per share
-1,26
-1,39
-1,69
-1,52
Interest and investment income
5,74 млн
5,52 млн
6,36 млн
5,35 млн
Interest expense
-1,96 млн
-1,90 млн
-1,82 млн
-1,85 млн
Net interest expenses
3,78 млн
3,61 млн
4,53 млн
3,50 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-83,80 млн
-94,07 млн
-124,99 млн
-112,36 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору